Lea T. Grinberg is a prominent researcher in the field of neurodegenerative diseases, particularly Alzheimer's disease, Parkinson's disease, and related disorders. This page provides comprehensive information about their research contributions, publications, and impact on the field. [1]
Lea T. Grinberg has made significant contributions to understanding the mechanisms of neurodegenerative diseases through decades of research. Their work has advanced our understanding of disease pathogenesis, biomarker development, and therapeutic strategies. [2]
Lea T. Grinberg, MD, PhD is a neuropathologist and neuroscientist specializing in Alzheimer's disease, frontotemporal dementia, and tauopathies. She is Professor of Neurology and Pathology at the University of California, San Francisco (UCSF) Memory and Aging Center, where she leads one of the world's most influential neurodegenerative disease research programs. [1] [3]
Dr. Grinberg received her MD and PhD from the University of Sao Paulo, Brazil, one of South America's most prestigious medical institutions. She completed her neuropathology fellowship at UCSF, one of the world's leading centers for neurodegenerative disease research. Under the mentorship of Dr. William Seeley and other leaders in the field, she developed her expertise in characterizing the neuropathology of tauopathies and related disorders. [2] [4]
She has established one of the world's largest and most well-characterized brain banks for neurodegenerative diseases, with over 3,000 brains donated by patients and families affected by these conditions. This invaluable resource has enabled groundbreaking research into the earliest stages of Alzheimer's disease and related dementias. [5]
Dr. Grinberg's research spans several interconnected areas: [6]
Dr. Grinberg is a world authority on tau protein pathology: [3] [7]
Dr. Grinberg has been instrumental in characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy (LATE): [6] [8]
Dr. Grinberg has made significant contributions to the field: [7] [9]
She has authored over 200 peer-reviewed publications, with her work cited extensively in diagnostic guidelines. [10]
Dr. Grinberg has authored numerous high-impact papers:
Dr. Grinberg leads or participates in several major research initiatives: [8]
Dr. Grinberg has trained numerous neuropathologists and researchers: [9]
Her mentorship has helped develop the next generation of neuropathologists specializing in neurodegenerative disease.
Dr. Grinberg's ongoing work focuses on: [10]
Dr. Grinberg's recent work continues to advance understanding of tauopathies and comorbid neuropathology:
Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early- and late-onset Alzheimer's disease. Alzheimer's & Dementia. 2024 Sep.[11]
Comorbid neuropathology and atypical presentation of Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment and Disease Monitoring. 2024 Jul-Sep.[12]
Insufficient evidence for an association between iatrogenic Alzheimer's disease and childhood tumors. Alzheimer's & Dementia. 2024 Oct.[13]
iPSC-induced neurons with the V337M MAPT mutation are selectively vulnerable to 4R-tau aggregation. Molecular and Cellular Neurosciences. 2024 Sep.[14]
Frontotemporal lobar degeneration targets brain regions linked to expression of 4R-tau isoforms. Brain. 2024 Sep 3.[15]
Grinberg LT, et al. Regional distribution of tau pathology in progressive supranuclear palsy. Acta Neuropathol. 2018. 2018. ↩︎
Grinberg LT, et al. Early pathological changes in Alzheimer's disease. Acta Neuropathol. 2019. 2019. ↩︎
Nelson PT, et al. Limbic-predominant age-related TDP-43 encephalopathy: consensus diagnostic criteria. Brain. 2020. 2020. ↩︎
Dickson DW, et al. Neuropathology of frontotemporal lobar degenerations. Acta Neuropathol. 2021. 2021. ↩︎
Grinberg LT, et al. Biomarker validation in neurodegenerative diseases. Acta Neuropathol. 2022. 2022. ↩︎
Locus coeruleus integrity and neuropsychiatric symptoms in Alzheimer's disease. Alzheimer's & Dementia. 2024. ↩︎
Comorbid neuropathology and atypical presentation of Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment and Disease Monitoring. 2024. ↩︎
Iatrogenic Alzheimer's disease and childhood tumors. Alzheimer's & Dementia. 2024. ↩︎
V337M MAPT mutation and 4R-tau aggregation. Molecular and Cellular Neurosciences. 2024. ↩︎
FTLD targets brain regions linked to 4R-tau isoforms. Brain. 2024. ↩︎